Detection and Typing of Human Papilloma Viruses by Nested Multiplex Polymerase Chain Reaction Assay in Cervical Cancer
- PMID: 26865940
- PMCID: PMC4745380
- DOI: 10.5812/jjm.26441
Detection and Typing of Human Papilloma Viruses by Nested Multiplex Polymerase Chain Reaction Assay in Cervical Cancer
Abstract
Background: Cervical cancer is the leading cause of death from cancer in under-developed countries. Human papilloma virus (HPV) 16 and 18 are the most prevalent types associated with carcinogenesis in the cervix. Conventional Polymerase Chain Reaction (PCR), type-specific and consensus primer-based PCR followed by sequencing, Restriction Fragment Length Polymorphism (RFLP) or hybridization by specific probes are common methods for HPV detection and typing. In addition, some researchers have developed a multiplex PCR for simultaneous detection and typing of different HPVs.
Objectives: The aim of the present study was to investigate the prevalence of HPV infection and its types in cervical Squamous Cell Carcinoma (SCC) using the Nested Multiplex PCR (NMPCR) assay.
Patients and methods: Sixty-six samples with histologically confirmed SCC were evaluated. Total DNA was isolated by phenol-chloroform extraction and ethanol precipitation. Nested multiplex PCR was performed with first-round PCR by GP-E6/E7 consensus primers for amplification of the genomic DNA of all known mucosal HPV genotypes and second-round PCR by type-specific multiplex PCR primer cocktails.
Results: Human papilloma virus infection was detected in 78.8% of samples, with the highest prevalence of HPV 16 (60.6%) while concurrent infections with two types was detected in 10.6%.
Conclusions: The NMPCR assay is more convenient and easy for analysis of results, which is important for fast diagnosis and patient management, in a type-specific manner.
Keywords: Carcinoma; Human Papillomavirus 16; Multiplex Polymerase Chain Reaction; Squamous Cell.
Figures
References
-
- Insinga RP, Liaw KL, Johnson LG, Madeleine MM. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2008;17(7):1611–22. doi: 10.1158/1055-9965.EPI-07-2922. - DOI - PMC - PubMed
-
- Fabiano V, Mariani L, Giovagnoli MR, Raffa S, Vincenzoni C, de Michetti F, et al. Cervical cancer screening program based on HPV testing and conventional Papanicolaou cytology for jail inmates. Health. 2010;2(09):1027–32. doi: 10.4236/health.2010.29151. - DOI
-
- Lepique AP, Rabachini T, Villa LL. HPV vaccination: The beginning of the end of cervical cancer? - A Review. Mem Inst Oswaldo Cruz. 2009;104(1):1–10. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials